0001567619-19-005281.txt : 20190222
0001567619-19-005281.hdr.sgml : 20190222
20190222172735
ACCESSION NUMBER: 0001567619-19-005281
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190219
FILED AS OF DATE: 20190222
DATE AS OF CHANGE: 20190222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HULME GEOFFREY
CENTRAL INDEX KEY: 0001307047
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 19627391
MAIL ADDRESS:
STREET 1: C/O PORTER ORLIN LLC
STREET 2: 666 FIFTH AVENUE, 34TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2019-02-19
2019-02-20
0
0001080014
Innoviva, Inc.
INVA
0001307047
HULME GEOFFREY
2000 SIERRA POINT PARKWAY
SUITE 500
BRISBANE
CA
94005
0
1
0
0
Interim PEO
Common Stock
2019-02-19
4
F
0
3093
14.53
D
12907
D
The form is being amended to reflect granted shares withheld by the Issuer to satisfy income tax withholding obligations incurred in connection with the grant of the restricted stock award described in the original filing.
/s/ Geoffrey L. Hulme
2019-02-22